Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Receivables Refunds (2016 - 2022)

Usana Health Sciences has reported Receivables Refunds over the past 10 years, most recently at $1.6 million for Q1 2022.

  • Quarterly Receivables Refunds rose 35.19% to $1.6 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Jan 2022, up 35.19% year-over-year, with the annual reading at $1.6 million for FY2022, 35.19% up from the prior year.
  • Receivables Refunds was $1.6 million for Q1 2022 at Usana Health Sciences, up from $1.2 million in the prior quarter.
  • Over five years, Receivables Refunds peaked at $6.4 million in Q4 2018 and troughed at $1.2 million in Q1 2021.
  • The 4-year median for Receivables Refunds is $1.8 million (2019), against an average of $2.8 million.
  • Year-over-year, Receivables Refunds crashed 68.1% in 2019 and then soared 35.19% in 2022.
  • A 4-year view of Receivables Refunds shows it stood at $6.4 million in 2018, then crashed by 68.1% to $2.0 million in 2019, then tumbled by 42.8% to $1.2 million in 2021, then soared by 35.19% to $1.6 million in 2022.
  • Per Business Quant, the three most recent readings for USNA's Receivables Refunds are $1.6 million (Q1 2022), $1.2 million (Q1 2021), and $2.0 million (Q4 2019).